BR112017006620A2 - vacina, métodos para a preparação de uma vacina e para reduzir infecção por reovírus aviário, composição, e, usos de material antigênico e de uma vacina. - Google Patents

vacina, métodos para a preparação de uma vacina e para reduzir infecção por reovírus aviário, composição, e, usos de material antigênico e de uma vacina.

Info

Publication number
BR112017006620A2
BR112017006620A2 BR112017006620A BR112017006620A BR112017006620A2 BR 112017006620 A2 BR112017006620 A2 BR 112017006620A2 BR 112017006620 A BR112017006620 A BR 112017006620A BR 112017006620 A BR112017006620 A BR 112017006620A BR 112017006620 A2 BR112017006620 A2 BR 112017006620A2
Authority
BR
Brazil
Prior art keywords
vaccine
avian reovirus
preparing
antigenic material
composition
Prior art date
Application number
BR112017006620A
Other languages
English (en)
Other versions
BR112017006620B1 (pt
Inventor
Pouwels Henk
Zande Van De Saskia
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of BR112017006620A2 publication Critical patent/BR112017006620A2/pt
Publication of BR112017006620B1 publication Critical patent/BR112017006620B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

é descrita uma vacina de amplo espectro contra reovírus aviário, que é efetiva na redução da infecção de reovírus aviário em uma ave alvo. a vacina compreende material antigênico derivado de reovírus aviário de dois grupos de genótipos: 1 e 4, como aqui definido. esta vacina é efetiva contra todos os reovírus aviários, homólogos ou heterólogos para a vacina, incluindo cepas virulentas provenientes de falha vacinal.
BR112017006620-3A 2014-10-03 2015-10-02 Vacina, métodos para a preparação de uma vacina e para reduzir infecção por reovírus aviário, composição, e, usos de material antigênico e de uma vacina BR112017006620B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14187650 2014-10-03
EP14187650.8 2014-10-03
PCT/EP2015/072810 WO2016050961A1 (en) 2014-10-03 2015-10-02 Broad-spectrum vaccine against avian reovirus

Publications (2)

Publication Number Publication Date
BR112017006620A2 true BR112017006620A2 (pt) 2017-12-12
BR112017006620B1 BR112017006620B1 (pt) 2023-12-26

Family

ID=51663053

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017006620-3A BR112017006620B1 (pt) 2014-10-03 2015-10-02 Vacina, métodos para a preparação de uma vacina e para reduzir infecção por reovírus aviário, composição, e, usos de material antigênico e de uma vacina

Country Status (9)

Country Link
US (1) US10493147B2 (pt)
EP (1) EP3200820B1 (pt)
CN (1) CN106794242B (pt)
BR (1) BR112017006620B1 (pt)
ES (1) ES2954910T3 (pt)
HU (1) HUE063529T2 (pt)
PL (1) PL3200820T3 (pt)
RU (1) RU2701808C2 (pt)
WO (1) WO2016050961A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3106341A1 (en) * 2018-07-13 2020-01-16 Biomune Company New vaccines against avian reoviruses
RU2750865C1 (ru) * 2020-04-09 2021-07-05 Федеральное государственное бюджетное научное учреждение "Федеральный научный центр - Всероссийский научно-исследовательский институт экспериментальной ветеринарии имени К.И. Скрябина и Я.Р. Коваленко Российской академии наук" (ФГБНУ ФНЦ ВИЭВ РАН) Поливалентная инактивированная вакцина против риемереллёза, пастереллёза и сальмонеллёза индеек, уток и гусей, способ её получения
CN113907046A (zh) * 2021-11-09 2022-01-11 福建省连江县刘氏兔业养殖场 一种含特异性转移因子的ty26种兔群的选育方法和相应兔品系的培育方法
CN117659139A (zh) * 2023-11-09 2024-03-08 中国兽医药品监察所 一种检测禽呼肠孤病毒抗体的间接elisa试剂盒

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US5525342A (en) 1994-05-20 1996-06-11 Akzo Nobel, N.V. Reovirus strain 2177 and vaccine containing same
EP1024189B1 (en) * 1999-01-29 2005-04-06 Akzo Nobel N.V. Novel antigenic class of avian reoviruses
AU2003296912A1 (en) * 2002-10-09 2004-05-04 Akzo Nobel N.V. Methods of treating and preventing neurological symptoms caused by avian reovirus and novel associated characteristics
TWI398272B (zh) 2005-03-08 2013-06-11 Intervet Int Bv 化學定義的安定劑
CN1895667B (zh) * 2006-06-06 2010-11-03 瑞普（保定）生物药业有限公司 一种呼肠孤病毒灭活疫苗及制备方法
US8178110B2 (en) * 2006-10-25 2012-05-15 University Of Georgia Research Foundation, Inc. Reovirus compositions and methods of use
WO2009093251A2 (en) 2008-01-24 2009-07-30 Gavish-Galilee Bio Applications Ltd Reovirus vaccine based on sigma c protein sequence
EP2471926A3 (en) 2010-12-30 2012-07-11 Intervet International BV Immunostimulatory oligodeoxynucleotides
CN103547675A (zh) 2011-05-26 2014-01-29 英特维特国际股份有限公司 免疫刺激性寡脱氧核苷酸
US9359602B2 (en) 2011-05-26 2016-06-07 Intervet Inc. Immunostimulatory oligodeoxynucleotides
WO2017066484A2 (en) * 2015-10-13 2017-04-20 Carter Daniel C Nsp10 self-assembling fusion proteins for vaccines, therapeutics, diagnostics and other nanomaterial applications

Also Published As

Publication number Publication date
PL3200820T3 (pl) 2023-09-18
EP3200820A1 (en) 2017-08-09
CN106794242B (zh) 2021-11-30
RU2017114503A (ru) 2018-11-06
US10493147B2 (en) 2019-12-03
ES2954910T3 (es) 2023-11-27
US20180326043A1 (en) 2018-11-15
WO2016050961A1 (en) 2016-04-07
EP3200820B1 (en) 2023-07-05
BR112017006620B1 (pt) 2023-12-26
CN106794242A (zh) 2017-05-31
RU2701808C2 (ru) 2019-10-01
HUE063529T2 (hu) 2024-01-28
RU2017114503A3 (pt) 2019-04-22

Similar Documents

Publication Publication Date Title
DOP2017000038A (es) 2-(morfolin-4-il)-1,7-naftiridinas
PE20180266A1 (es) Composiciones que comprenden cepas bacterianas
AR102657A1 (es) Composición para tratar telas
PE20180243A1 (es) Composiciones que comprenden cepas bacterianas
BR112017010177A2 (pt) composição para tratamento de tecido
BR112016027136A2 (pt) Válvula protética para tratamento de doenças que causam refluxo afetando os membros inferiores
BR112018010503A2 (pt) ovo de ave, método para replicar um vírus, vírus, método para produzir uma composição de vacina, composição de vacina, ave transgênica, e método para produzir uma ave
BR112017006620A2 (pt) vacina, métodos para a preparação de uma vacina e para reduzir infecção por reovírus aviário, composição, e, usos de material antigênico e de uma vacina.
BR112015025748A2 (pt) construção de dna para imunomodulação, composição farmacêutica, vacina, e uso de uma construção de dna
CL2015001772A1 (es) Composición farmacéutica para el tratamiento de dolor cabeza, y método de preparación de la misma.
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
DOP2016000336A (es) Derivados de isoindolina para uso en el tratamiento de una infeccion viral
BR112017000519A2 (pt) "composição imunogênica, e, método para proteger um mamífero contra uma infecção meningocócica"
BR112017003462A2 (pt) coronavírus bovino atenuado, vacina, e, método de vacinação de um bovino.
BR112016030294A8 (pt) cepa de bactérias probióticas de lactobacillus e uma vacina de aves domésticas, composição, ovo de aves domésticas embrionado, kit, e, método de vacinação in ovo de aves domésticas
BR112018014590A2 (pt) formulações/composições compreendendo um inibidor de btk
BR112016024096A2 (pt) novo bacteriófago e composição compreendendo o mesmo
BR112017003891A2 (pt) métodos e composições para induzir imunidade protetora contra infecção por filovírus
DOP2016000297A (es) Composiciones farmacéuticas útiles para tratar enfermedades infecciosas
CO2017003840A2 (es) Formulación esterilizada por calor que comprende quitosán y proceso para preparación de la misma
BR112018010692A2 (pt) composições imunoestimuladoras, usos de melanina ou de um precursor da melanina e método para obter uma composição imunoestimuladora
BR112018014042A2 (pt) vírus do tipo orthomyxo da tilápia.
BR112018077210A8 (pt) Vírus de enterite de pato e usos do mesmo
UY36217A (es) Compuestos piridona sustituídos, composiciones farmacéuticas y métodos de uso.
BR112017023448A2 (pt) composições anti-fitopatogênicas

Legal Events

Date Code Title Description
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 02/10/2015, OBSERVADAS AS CONDICOES LEGAIS